Yayınlar & Eserler

Yayın Ağı
Makaleler 193
Tümü (193)
SCI-E, SSCI, AHCI (174)
SCI-E, SSCI, AHCI, ESCI (184)
ESCI (7)
Scopus (185)
TRDizin (24)

1. Genetic susceptibility and validation of angiographic patterns in Takayasu arteritis

Casares-Marfil D., Gribbons K. B., Saruhan-Direskeneli G., Kaymaz-Tahra S., Quinn K. A., ALİBAZ ÖNER F., et al.
Journal of Autoimmunity , cilt.157, 2025 (SCI-Expanded, Scopus) identifier identifier

2. Advances in the pathophysiology, diagnosis and treatment of Takayasu arteritis.

Sawalha A. H., Misra D. P., Goel R., Alibaz-Oner F., Quinn K. A., Grayson P. C., et al.
Nature reviews. Rheumatology , cilt.21, ss.737-751, 2025 (SCI-Expanded, Scopus) identifier identifier

3. Deep venous thrombosis can reveal Behçet's Disease in young males in countries with high prevalence: A retrospective study.

Karakök Ö., Bozkurt T., Ergun T., Direskeneli H., Alibaz-Oner F.
Annals of vascular surgery , cilt.121, ss.477-479, 2025 (SCI-Expanded, Scopus) identifier identifier

4. Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study

Trottet C., Schürch M., Allam A., Petelytska L., Castellví I., Bečvář R., et al.
npj Digital Medicine , cilt.8, sa.1, 2025 (SCI-Expanded, Scopus) identifier identifier

5. Risk of major organ involvement in Behçet's patients with mucocutaneous onset: data from the AIDA Network Registry.

Vitale A., Gavioli F., Caggiano V., Sbalchiero J., Lopalco G., Ragab G., et al.
Rheumatology (Oxford, England) , 2025 (SCI-Expanded, Scopus) identifier

6. The Risk of Developing Ocular Involvement Among Behçet's Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet's Disease Registry.

Vitale A., Caggiano V., Sbalchiero J., Lopalco G., Ragab G., Guerriero S., et al.
Ophthalmology and therapy , 2025 (SCI-Expanded, Scopus) identifier

7. Turkish Society for Rheumatology (Turkish Takayasu Arteritis Study Group) recommendations for the diagnosis, follow-up and the treatment of Takayasu's arteritis.

Alibaz-Öner F., Kaymaz-Tahra S., Ince B., Bölek E. Ç., Yüce Inel T., Öz H. E., et al.
Clinical and experimental rheumatology , cilt.43, ss.1928-1944, 2025 (SCI-Expanded, Scopus) identifier identifier

8. Upper extremity function and strength, assessed with unsupported upper limb exercise test (UULEX), is impaired in patients with Takayasu Arteritis.

Temiz F., Ağyol Y., Abacar K., Özdemir B., Sevim H., Güner M., et al.
Modern rheumatology , cilt.35, ss.981-988, 2025 (SCI-Expanded, Scopus) identifier identifier

9. Prognostic significance and rationality of regular non-invasive imaging follow-up in Takayasu arteritis: A large multicenter cohort study

Yıldırım F., Tastekin F., Bakkal S., Kutu M. E., Ocak T., San S., et al.
Seminars in Arthritis and Rheumatism , cilt.74, 2025 (SCI-Expanded, Scopus) identifier identifier

10. Phenotypic clusters of patients with Takayasu arteritis predict disease activity at presentation, damage and future vascular complications.

Avcu A., Jose A., Ganapathy S., Alibaz-Oner F., Kavadichanda C., Rathore U., et al.
Rheumatology (Oxford, England) , 2025 (SCI-Expanded, Scopus) identifier

11. Cluster and correspondence analyses for oral ulcer activity related factors in Behçet's syndrome

Polat-Akmansoy B., Aksoy B., Şişman-Kitapçı N., Akmansoy Ş. C., Çandereli Z., Sarı F., et al.
Medicina oral, patologia oral y cirugia bucal , cilt.30, sa.5, 2025 (SCI-Expanded, Scopus) identifier identifier

12. Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry.

Sota J., Mejía-Salgado G., Guerriero S., Ragab G., Costi S., Paroli M. P., et al.
Frontiers in medicine , cilt.12, ss.1609613, 2025 (SCI-Expanded, Scopus) identifier identifier

13. Clinical Features and Phenotypic Similarities of Patients with Familial Behçet's Disease.

Abacar K., Boncukcuoğlu A. E., Deniz R., Uludogan B. C., Kaş D., Alkan E., et al.
European journal of rheumatology , cilt.12, sa.2, ss.1-5, 2025 (ESCI) identifier

14. Clinical course of pediatric-onset Behçet's Disease in young adulthood.

Bozkurt T., Yıldız M., Deniz R., Yazıcı A., Karabacak M., Karataş H., et al.
Rheumatology (Oxford, England) , cilt.64, ss.2876-2881, 2025 (SCI-Expanded, Scopus) identifier identifier

15. The Assessment of Perceived Stress, Anxiety, Depression, Insomnia, Sleep Quality, and Drug Adherence in Patients with Systemic Lupus Erythematosus During the COVID-19 Pandemic.

Gokmen K., Barutcu Atas D., Tugcu M., Velioglu A., Arikan H., Alibaz Oner F., et al.
European journal of rheumatology , cilt.12, sa.2, ss.1-7, 2025 (ESCI) identifier

16. Screening for familial disease presence in first-degree relatives of Behçet's disease patients: Is measurement of common femoral vein wall thickness valuable for the diagnosis?

Boncukcuoğlu A. E., Topal E., Ergelen R., Kaş D., Alkan E., Kaya G., et al.
Modern rheumatology , cilt.35, ss.371-377, 2025 (SCI-Expanded, Scopus) identifier identifier

17. The evaluation of myocarditis in patients with Still's disease; clinical findings from the multicentre international AIDA Network Still's Disease Registry.

Ruscitti P., Di Cola I., Vitale A., Caggiano V., Palumbo P., Di Cesare E., et al.
The Journal of rheumatology , cilt.52, ss.226-233, 2025 (SCI-Expanded, Scopus) identifier identifier

18. Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry

Sota J., Ragab G., AlMaglouth I., Lopalco G., TUFAN A., DİRESKENELİ R. H., et al.
Joint Bone Spine , cilt.92, sa.2, 2025 (SCI-Expanded) identifier identifier

19. Assessment of cardiac function and left ventricular dyssynchrony in patients with ANCA-associated vasculitis using speckle-tracking echocardiography

Demirci M., Özben B., AŞICIOĞLU E., Karaaslan M., Ataş D. B., ALİBAZ ÖNER F., et al.
Postepy w Kardiologii Interwencyjnej , cilt.21, sa.3, ss.373-380, 2025 (SCI-Expanded, Scopus) identifier identifier

20. Behçet’s Disease with Intestinal Involvement Can be Distinguished from Inflammatory Bowel Diseases by Measurement of Common Femoral Vein Wall Thickness

SEVİK G., ERGELEN R., Ergenc I., SOYDEMİR E., TEMİZ F., ATUĞ Ö., et al.
Mediterranean Journal of Rheumatology , cilt.36, sa.2, ss.268-272, 2025 (Scopus) identifier identifier

21. Development and implementation of the International AIDA Network Castleman’s disease registry

Vitale A., Sbalchiero J., Caggiano V., Lazzi S., Tharwat S., Fotis L., et al.
Frontiers in Medicine , cilt.12, 2025 (SCI-Expanded, Scopus) identifier identifier

22. Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders.

Sota J., Guerriero S., Lopalco G., Tufan A., Ragab G., AlMaglouth I., et al.
Ocular immunology and inflammation , cilt.33, sa.1, ss.48-55, 2025 (SCI-Expanded, Scopus) identifier identifier

23. Long-term outcomes of aortic valve insufficiency in patients with Takayasu arteritis

Yağmur F. H., Kutu M. E., Tastekin F., Avcu A., Şan S., Ocak T., et al.
Frontiers in Immunology , cilt.16, 2025 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

24. Optic Disc and Retinal Structural Changes in Takayasu Arteritis: Implications for Normotensive Glaucoma

Bulut Kızılay E., Esen F., Kızılay M. E., DİRESKENELİ R. H., ALİBAZ ÖNER F.
Ocular Immunology and Inflammation , cilt.33, sa.9, ss.2121-2127, 2025 (SCI-Expanded, Scopus) identifier identifier

25. Cytokine Signature Differences in Major Phenotypic Groups of Behçet Disease

Deniz R., EMRENCE Z., Punar Ş., İleri B., ARGA K. Y., ALİBAZ ÖNER F., et al.
Journal of Clinical Rheumatology , cilt.30, sa.8, 2024 (SCI-Expanded, Scopus) identifier identifier

26. Analysis of proinflammatory cytokine responses in Takayasu arteritis

Deniz R., TULUNAY VİRLAN A., Ozdemir F. T., Unal A. U., Ozen G., ALİBAZ ÖNER F., et al.
Archives of Rheumatology , cilt.39, sa.4, ss.598-606, 2024 (SCI-Expanded) identifier identifier

27. Does Extended Vascular Screening Be Performed in All Asymptomatic Behçet's Disease Patients With Previously Diagnosed Vascular Involvement or Unexplained Inflammatory Response?

DİRESKENELİ R. H., Yiğit Abacar K., ALİBAZ ÖNER F.
International Journal of Rheumatic Diseases , cilt.27, sa.12, 2024 (SCI-Expanded) identifier identifier

28. Anticoagulant Treatment May Decrease the Relapse Rate of Pulmonary Arterial Involvement in Behçet's Disease.

Abacar K. Y., Boncukcuoglu A. E., Aksoy A., Kocakaya D., Cimsit C., Direskeneli H., et al.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases , cilt.30, sa.8, ss.303-308, 2024 (SCI-Expanded, Scopus) identifier identifier

29. Infections in ANCA-associated vasculitis and lupus nephritis treated with rituximab

Temiz S. G., BARUTÇU ATAŞ D., ALİBAZ ÖNER F., VELİOĞLU A., Hakki Arikan İ. H., TUĞLULAR Z. S., et al.
Marmara Medical Journal , cilt.37, sa.3, ss.268-273, 2024 (ESCI) identifier

30. Carotid intima-media thickness correlated with age and pulse wave velocity in ANCA-associated vasculitis patients

İZGİ T. N., Barutcu Atas D., ATAŞ H., Akaslan D., ILGIN C., Velioglu A., et al.
Marmara Medical Journal , cilt.37, sa.3, ss.290-294, 2024 (ESCI) identifier

31. Assessment of venous disease with different venous disease specific scales in Behçet’s disease patients with deep vein thrombosis

AKSOY A., Colak S., YAĞIZ B., COŞKUN B. N., Omma A., Sarı A., et al.
Phlebology , cilt.39, sa.8, ss.550-556, 2024 (SCI-Expanded) identifier identifier

32. Clinical Characteristics and Outcomes of Polyarteritis Nodosa - an International Study.

Karadag O., Bolek E. C., Ayan G., Mohammad A. J., Grayson P. C., Pagnoux C., et al.
Arthritis & rheumatology (Hoboken, N.J.) , cilt.76, sa.7, ss.1120-1129, 2024 (SCI-Expanded, Scopus) identifier identifier

33. The systemic score may identify life-threatening evolution in Still's disease: data from the GIRRCS AOSD-study group and the AIDA Network Still's Disease Registry.

Ruscitti P., Masedu F., Vitale A., Caggiano V., Di Cola I., Cipriani P., et al.
Arthritis & rheumatology (Hoboken, N.J.) , cilt.76, ss.1141-1152, 2024 (SCI-Expanded, Scopus) identifier identifier

34. Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritis

Kaymaz-Tahra S., Bayindir O., Ince B., Ozdemir İsik O., Kutu M. E., Karakas O., et al.
Seminars in Arthritis and Rheumatism , cilt.66, 2024 (SCI-Expanded, Scopus) identifier identifier

35. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

BİLGİN E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., KARABACAK M., Sadioğlu Çağdaş Ö., et al.
Internal and Emergency Medicine , cilt.19, sa.4, ss.1025-1034, 2024 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

36. The mediator role of treatment response on oral health related quality of life in Behçet's syndrome.

Altıngöz E., Yenisoy Y., Kapusuz A., Abacar K., Şişman-Kitapçı N., Yay M., et al.
Medicina oral, patologia oral y cirugia bucal , cilt.29, ss.350-355, 2024 (SCI-Expanded, Scopus) identifier identifier

37. Frequency and the effects of spondyloarthritis-spectrum disorders on the clinical course and management of Takayasu arteritis: an observational retrospective study

Abacar K., Kaymaz-Tahra S., Bayındır Ö., İnce B., Kutu M. E., YAZICI A., et al.
Clinical Rheumatology , cilt.43, sa.5, ss.1571-1578, 2024 (SCI-Expanded, Scopus) identifier identifier

38. Development of the Takayasu's Arteritis Integrated Disease Activity Index.

Marvisi C., Bolek E. C., Ahlman M. A., Alessi H., Redmond C., Muratore F., et al.
Arthritis care & research , cilt.76, ss.531-540, 2024 (SCI-Expanded, Scopus) identifier identifier

39. Increased inferior vena cava wall thickness as a sign of extensive venous inflammation in Behçet's Disease.

Ağaçkıran S. K., Sünbül M., Doğan Z., Direskeneli H., Alibaz-Oner F.
Clinical rheumatology , cilt.43, ss.1355-1362, 2024 (SCI-Expanded, Scopus) identifier identifier

40. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.

Alibaz-Öner F., Kelesoglu B., Balci M. A., Yardimci G. K., Armağan B., Kiliç L., et al.
Clinical and experimental rheumatology , cilt.42, ss.816-821, 2024 (SCI-Expanded) identifier identifier

41. Common femoral vein wall thickness measurement as a diagnostic test in suspected Behçet's Disease.

Alibaz-Oner F., Ergelen R., Kutluğ-Ağaçkıran S., Temiz F., Ergun T., Direskeneli H.
Rheumatology (Oxford, England) , cilt.63, 2024 (SCI-Expanded) Creative Commons License identifier identifier

42. Common femoral vein wall thickness measurement by Doppler ultrasonography is an accurate diagnostic test for Behçet's Disease both in supine and standing positions.

Ergelen R., Kutluğ Ağaçkıran S., Direskeneli H., Alibaz-Oner F.
Phlebology , 2024 (SCI-Expanded) identifier identifier

43. Angiographic findings of pulmonary arterial involvement in Behcet's Disease: Do they correlate with symptoms and acute phase response?

Aksoy A., Kocakaya D., Demircioglu O., Cimsit N. Ç., Yildizeli B., Karakurt S., et al.
Respiratory medicine , cilt.221, ss.107481, 2024 (SCI-Expanded, Scopus) identifier identifier

44. Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's Disease.

Vitale A., Caggiano V., Sfikakis P. P., Dagna L., Lopalco G., Ragab G., et al.
Frontiers in medicine , cilt.10, ss.1256243, 2023 (SCI-Expanded) Creative Commons License identifier identifier

45. Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry.

Vitale A., Caggiano V., Lopalco G., Mayrink Giardini H. A., Ciccia F., Almaghlouth I. A., et al.
RMD open , cilt.9, sa.4, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

46. Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry

Triggianese P., Vitale A., Lopalco G., Mayrink Giardini H. A., Ciccia F., Al-Maghlouth I., et al.
Internal and Emergency Medicine , cilt.18, sa.8, ss.2231-2243, 2023 (SCI-Expanded) Creative Commons License identifier identifier

47. Hypogammaglobulinemia and severe infection risk in patients with autoimmune diseases during rituximab treatment Otoimmün hastalığı olan hastalarda rituksimab tedavisi sırasında hipogamaglobulinemi ve enfeksiyon riski

Kaymaz Tahra S., ALİBAZ ÖNER F., KAPLAN T., Yalçınkaya Y., İNANÇ G. N., ATAGÜNDÜZ M. P., et al.
Journal of Turkish Society For Rheumatology , cilt.15, sa.3, ss.154-161, 2023 (Scopus) identifier identifier

48. Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry.

Ruscitti P., Masedu F., Vitale A., Di Cola I., Caggiano V., Di Muzio C., et al.
RMD open , cilt.9, sa.4, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

49. Endothelial dysfunction, thrombophilia, and nailfold capillaroscopic features in livedoid vasculopathy.

Apti Sengun O., Ergun T., Guctekin T., Alibaz Oner F.
Microvascular research , cilt.150, ss.104591, 2023 (SCI-Expanded) identifier identifier

50. Does decision tree analysis predict oral ulcer activity-related factors in patients with Behçet's syndrome?

ÇANDERELİ Z. Ö., Arslan T., Özdamar Ö., Yay M., Karaçayli Ü., ŞİŞMAN KİTAPÇI N., et al.
Clinical and experimental rheumatology , cilt.41, sa.10, ss.2078-2086, 2023 (SCI-Expanded, Scopus) identifier identifier

51. The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry.

Ruscitti P., Sota J., Vitale A., Lopalco G., Iannone F., Morrone M., et al.
Seminars in arthritis and rheumatism , cilt.62, ss.152244, 2023 (SCI-Expanded) identifier identifier

52. Clinical trait-specific genetic analysis in Behçet's disease identifies novel loci associated with ocular and neurological involvement.

Casares-Marfil D., Esencan D., Alibaz-Oner F., Çefle A., Yazıcı A., Duzgun N., et al.
Clinical immunology (Orlando, Fla.) , cilt.253, ss.109657, 2023 (SCI-Expanded) identifier identifier

53. Intima-media thickness of common femoral vein is increased in Behçet's disease.

Sevik G., Ergelen R., Ağaçkıran S. K., Direskeneli H., Alibaz-Oner F.
Clinical immunology (Orlando, Fla.) , cilt.250, ss.109306, 2023 (SCI-Expanded) identifier identifier

54. Pulmonary arterial wall thickness is increased in Behçet's disease patients with major organ ınvolvement: Is it a sign of severity?

Ağaçkıran S. K., Sünbül M., Doğan Z., Kocakaya D., Kayacı S., Direskeneli H., et al.
Rheumatology (Oxford, England) , cilt.62, ss.1238-1242, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

55. Earlier and more aggressive treatment with biologics may prevent relapses and further new organ involvement in Behçet's disease

BOZKURT T., KARABACAK M., Karatas H., KUTLUĞ AĞAÇKIRAN S., Ergun T., DİRESKENELİ R. H., et al.
Clinical Immunology , cilt.248, 2023 (SCI-Expanded) identifier identifier identifier

56. RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy

Ergenç İ., KANİ H. T., KARABACAK M., CÖMERT ÖZER E., Mehdiyev S., Jafarov F., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.34, sa.3, ss.310, 2023 (SCI-Expanded) identifier identifier

57. Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B.

Ergenç İ., Kani H. T., Karabacak M., Cömert Özer E., Mehdiyev S., Jafarov F., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.34, sa.2, ss.156-160, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier identifier

58. Vascular Behçet syndrome: from pathogenesis to treatment

Bettiol A., ALİBAZ ÖNER F., DİRESKENELİ R. H., HATEMİ G., Saadoun D., SEYAHİ E., et al.
Nature Reviews Rheumatology , cilt.19, sa.2, ss.111-126, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

59. Update on the Diagnosis of Behçet’s Disease

ALİBAZ ÖNER F., DİRESKENELİ R. H.
Diagnostics , cilt.13, sa.1, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

60. C-Reactive Protein to Albumin Ratio is Associated with Disease Activity in Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis

Atas D. B., Sahin G. K., ŞENGÜL Ş., KAYA B., PAYDAŞ S., ALİBAZ ÖNER F., et al.
Mediterranean Journal of Rheumatology , cilt.34, sa.1, ss.71-77, 2023 (Scopus) identifier identifier

61. Multimodal Approach of Isolated Pulmonary Vasculitis: A Single-Institution Experience

Yanartaş M., Karakoç A. Z., Zengin A., Taş S., Olgun Yildizeli Ş., Mutlu B. L., et al.
ANNALS OF THORACIC SURGERY , cilt.114, sa.4, ss.1253-1261, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

62. Potential protective effects of chronic aerobic exercise on cardiopulmonary health and vascular function in takayasu arteritis

Yerli N. H., Abacar K., Alibaz-Oner F., DİRESKENELİ R. H., Kasimay O.
ACTA PHYSIOLOGICA , cilt.236, ss.393-396, 2022 (SCI-Expanded) identifier

63. Sex-specific analysis in Behçet's disease reveals higher genetic risk in male patients.

Jo Y. G., Fernández L. O., Coit P., Yilmaz V., Yentür S. P., Alibaz-Oner F., et al.
Journal of autoimmunity , cilt.132, ss.102882, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

64. Vascular Behçet's disease: a comparative study from Turkey and France.

Alibaz-Oner F., Vautier M., Aksoy A., Mirouse A., Le Joncour A., Cacoub P., et al.
Clinical and experimental rheumatology , cilt.40, ss.1491-1496, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

65. Vascular Behcet's disease: a comparative study from Turkey and France

Alibaz-Oner F., Vautier M., Aksoy A., Mirouse A., Le Joncour A., Cacoub P., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.40, sa.8, ss.1491-1496, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

66. Metabolic syndrome is associated with increased cardiovascular risk and disease damage in patients with Takayasu arteritis.

Sağlam B., Kaymaz-Tahra S., Kenar G., Kocaer S., Omma A., Erden A., et al.
International journal of rheumatic diseases , cilt.25, sa.7, ss.775-780, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

67. PROGNOSTIC VALUE OF COMMON FEMORAL VEIN WALL THICKNESS IN BEHCET DISEASE: A PROSPECTIVE FOLLOW-UP STUDY

Abacar K., Ergelen R., Temiz F., Yildiz Y., Ergun T., DİRESKENELİ R. H., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1041, 2022 (SCI-Expanded) Creative Commons License identifier

68. CORONARY ARTERIAL INVOLVEMENT CAN BE OBSERVED IN A SIGNIFICANT SUBSET OF TAKAYASU'S ARTERITIS PATIENTS BY CORONARY CT-ANGIOGRAPHY

Abacar K., Cincin A., Baltacioglu F., AKDENİZ DOĞAN Z. D., Sevik G., DİRESKENELİ R. H., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.701, 2022 (SCI-Expanded) Creative Commons License identifier

69. PULMONARY ARTERY WALL THICKNESS IS INCREASED IN BEHCET'S DISEASE

Agackiran S. K., Sunbul M., Kocakaya D., Kayaci S., DİRESKENELİ R. H., Alibaz-Oner F.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1023-1024, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier

70. EARLIER AND MORE AGGRESSIVE TREATMENT OF MAJOR ORGAN INVOLVEMENT WITH BIOLOGICS MAY PREVENT RELAPSES OR FURTHER NEW ORGAN INVOLVEMENT IN A SUBGROUP OF BEHCET'S DISEASE PATIENTS

Bozkurt T., Karabacak M., Karatas H., Agackiran S. K., Ergun T., DİRESKENELİ R. H., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.345-346, 2022 (SCI-Expanded) Creative Commons License identifier

71. THE COURSE AND OUTCOMES OF COVID-19 IN PATIENTS WITH TAKAYASU ARTERITIS: CASE SERIES OF 15 PATIENTS FROM A TERTIARY SINGLE CENTER

Sevik G., Agackiran S. K., Abacar K., Aliyeva A., DİRESKENELİ R. H., Alibaz-Oner F.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.972-973, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier

72. COMMON FEMORAL VEIN THICKNESS MEASUREMENT AS A DIAGNOSTIC TEST IN INCOMPLETE BEHCET'S DISEASE

Alibaz-Oner F., Ergelen R., Temiz F., Agackiran S. K., Soydemir E., Ergun T., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1446-1447, 2022 (SCI-Expanded) Creative Commons License identifier

73. INCREASED INFERIOR VENA CAVA WALL THICKNESS AS A SIGN OF VENOUS INFLAMMATION IN BEHCET'S DISEASE

Agackiran S. K., Sunbul M., DİRESKENELİ R. H., Alibaz-Oner F.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1024, 2022 (SCI-Expanded) Creative Commons License identifier

74. THE RELATIONSHIP BETWEEN PERCEIVED STRESS WITH ANXIETY, DEPRESSION, SLEEP QUALITY, INSOMNIA AND DRUG ADHERENCE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS DURING THE COVID-19 PANDEMIC

GÖKMEN YILDIRIM K., BARUTÇU ATAŞ D., TUĞCU M., VELİOĞLU A., ARIKAN İ. H., ALİBAZ ÖNER F., et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.37, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

75. Pulmonary Endarterectomy in Patients with Antiphospholipid Syndrome-Associated Chronic Thromboembolic Pulmonary Hypertension.

Taş S., Antal A., Durusoy A. F., Yanartaş M., Yıldız K., Olgun Yıldızeli Ş., et al.
Anatolian journal of cardiology , cilt.26, sa.5, ss.394-400, 2022 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

76. Fibroscan detection of fatty liver and liver fibrosis in patients with systemic lupus erythematosus.

Yetginoglu O., Atas D., Yilmaz Y., Velioglu A., Arikan H., Alibaz-Oner F., et al.
Lupus , cilt.31, sa.6, ss.723-729, 2022 (SCI-Expanded) identifier identifier identifier

77. The assessment of presenteeism and activity impairment in Behçet's syndrome and recurrent aphthous stomatitis: a multicentre study.

Karacayli U., Adesanya A., Aksoy A., Belem J. M. F. M., Cardin N. B., Sarı F. B., et al.
Rheumatology (Oxford, England) , cilt.61, sa.4, ss.1538-1547, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

78. Pregnancy in Takayasu's arteritis has a high risk of hypertension-related fetomaternal complications: A retrospective study of a Turkish cohort.

Gönenli M. G., Kaymaz Tahra S., Kara M., Keser G., Yazıcı A., Erden A., et al.
International journal of rheumatic diseases , cilt.25, sa.2, ss.140-146, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

79. Assessment of Takayasu arteritis in routine practice with PETVAS, an 18F-FDG PET quantitative scoring tool.

Kaymaz Tahra S., Özgüven S., Ünal A. U., Alibaz Öner F., Öneş T., Erdil T. Y., et al.
Turkish journal of medical sciences , cilt.52, ss.313-322, 2022 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

80. Myocardial involvement in Behcet's disease may be higher in patients with Neuro-Behcet's disease: a speckle tracking echocardiographic study

SÜNBÜL M., MİDİ İ., KUTLUĞ AĞAÇKIRAN S., ENGİN E., Ucem S., ALİBAZ ÖNER F., et al.
ACTA CARDIOLOGICA , cilt.77, sa.6, ss.515-523, 2022 (SCI-Expanded) identifier identifier identifier

81. The prevalence of non-vascular pulmonary manifestations in Takayasu's Arteritis patients: A Retrospective multi-centred Turkish cohort study.

Yazici A., Kaymaz-Tahra S., Ozdemir Isik O., Kara M., Alpay-Kanitez N., Gerçik O., et al.
Scandinavian journal of rheumatology , cilt.51, sa.4, ss.304-308, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

82. Prediction of subclinical left ventricular dysfunction by speckle-tracking echocardiography in patients with anti-neutrophil cytoplasmic antibody--associated vasculitis.

Izgi T. N., Atas D., ATAŞ H., Akaslan D., Ilgin C., VELİOĞLU A., et al.
Archives of rheumatology , cilt.37, sa.1, ss.129-135, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

83. FRAX scores are increased in patients with ANCA-associated vasculitis.

Cetin B., Cetin E. A., Arikan H., Velioglu A., Alibaz-Oner F., Direskeneli H., et al.
International urology and nephrology , cilt.53, sa.11, ss.2333-2339, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

84. Predictors for the Risk and Severity of Post Thrombotic Syndrome in Vascular Behcet's Disease.

Aksoy A., Çolak S., Yağız B., Coşkun B. N., Omma A., Yıldız Y., et al.
Journal of vascular surgery. Venous and lymphatic disorders , cilt.9, ss.1451-1459, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

85. Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab.

Alibaz-Oner F., Kaymaz-Tahra S., Bayındır Ö., Yazici A., Ince B., Kalkan K., et al.
Seminars in arthritis and rheumatism , cilt.51, sa.6, ss.1224-1229, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

86. Biologic treatments in Behçet's disease.

Alibaz-Öner F., Direskeneli H.
European journal of rheumatology , cilt.8, ss.217-222, 2021 (ESCI, TRDizin) identifier identifier identifier identifier

87. HADS-depression score is a mediator for illness perception and daily life impairment in Takayasu's arteritis.

Erdal S., Nalbantoğlu B., Gür M. B., Yıldırım M., Kılıçarslan A., Kaymaz-Tahra S., et al.
Clinical rheumatology , cilt.40, ss.4109-4116, 2021 (SCI-Expanded) identifier identifier identifier

88. Risk of tuberculosis is increased in Behçet’s disease compared to other rheumatological disorders after anti-TNFα treatments: a case series and review of the literature

Gazel Ü., Kocakaya D., TopÇu İ. H., KarataŞ H. Ö., Karabacak M., AtagÜndÜz M. P., et al.
Turkish journal of medical sciences , cilt.51, sa.4, ss.1689-1694, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier identifier

89. Femoral Vein Wall Thickness Measurement May Be a Distinctive Diagnostic Tool to Differentiate Behçet's Disease with Intestinal Involvement and Crohn's Disease.

Alibaz-Oner F., Ergelen R., Ergenc I., Seven G., Yazıcı A., Cefle A., et al.
Digestive diseases and sciences , cilt.66, sa.8, ss.2750-2755, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

90. Genetic association of a gain of function interferon gamma receptor 1 (IFNGR1) polymorphism and the intergenic region LNCAROD/DKK1 with Behçet's disease.

Ortiz Fernández L., Coit P., Yilmaz V., Yentür S. P., Alibaz-Oner F., Aksu K., et al.
Arthritis & rheumatology (Hoboken, N.J.) , cilt.73, ss.1244-1252, 2021 (SCI-Expanded) identifier identifier identifier

91. The prevalence of metabolic syndrome is increased in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis

Atas D., Atas H., İzgi T. N., Velioglu A., Arikan H., Oner F., et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.53, sa.7, ss.1427-1434, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

92. Advances in the Treatment of Behcet's Disease

ALİBAZ ÖNER F., DİRESKENELİ R. H.
CURRENT RHEUMATOLOGY REPORTS , cilt.23, sa.6, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

93. FIBROSCAN DETECTION OF FATTY LIVER AND LIVER FIBROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS

YETGİNOĞLU Ö., Atas D. B., VELİOĞLU A., ARIKAN İ. H., YILMAZ Y., ALİBAZ ÖNER F., et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.36, ss.172, 2021 (SCI-Expanded) identifier

94. Femoral vein wall thickness measurement: A new diagnostic tool for Behçet's disease.

Alibaz-Oner F., Ergelen R., Yıldız Y., Aldag M., Yazici A., Cefle A., et al.
Rheumatology (Oxford, England) , cilt.60, sa.1, ss.288-296, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

95. Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study.

Ortiz-Fernández L., Saruhan-Direskeneli G., Alibaz-Oner F., Kaymaz-Tahra S., Coit P., Kong X., et al.
American journal of human genetics , cilt.108, ss.84-99, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

96. Childhood-onset versus adult-onset Takayasu arteritis: A study of 141 patients from Turkey.

Karabacak M., Kaymaz-Tahra S., Şahin S., Yıldız M., Adroviç A., Barut K., et al.
Seminars in arthritis and rheumatism , cilt.51, ss.192-197, 2020 (SCI-Expanded) identifier identifier identifier

97. Moderation analysis exploring associations between age and mucocutaneous activity in Behçet's syndrome: A multicenter study from Turkey.

MUMCU G., Yay M., Karacayli U., Aksoy A., Tas M. N., Armagan B., et al.
The Journal of dermatology , cilt.47, sa.12, ss.1403-1410, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

98. Decreasing incidence and severity of Behçet’s disease: a changing trend in epidemiological spectrum possibly associated with oral health

Mumcu G., Alibaz Ö., Ergun S. A. T., Direskeneli R. H.
Turkish journal of medical sciences , cilt.50, sa.SI-2, ss.1587-1590, 2020 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier

99. Assessment of damage in Takayasu's arteritis.

Kaymaz-Tahra S., Alibaz-Oner F., Direskeneli H.
Seminars in arthritis and rheumatism , cilt.50, ss.586-591, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

100. Damage assessment in adult IgA vasculitis. Cross-sectional results of a multicentre cohort.

Gazel U., Colak S., Sari A., Cansu D., Yazici A., Cefle A., et al.
Clinical and experimental rheumatology , cilt.38, sa.2, ss.155-160, 2020 (SCI-Expanded) identifier identifier identifier

101. Predictive factors for work-day loss in Behçet's syndrome: A multi-center study.

MUMCU G., Yay M., AKSOY A., Tas M. N., ARMAĞAN B., Sari A., et al.
International journal of rheumatic diseases , cilt.23, sa.2, ss.240-246, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

102. Efficacy of TNFα inhibitors for refractory vascular Behçet's disease: A multicenter observational study of 27 patients and a review of the literature.

Aksoy A., Yazici A., Omma A., Cefle A., Onen F., Tasdemir U., et al.
International journal of rheumatic diseases , cilt.23, sa.2, ss.256-261, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

103. Oral ulcer activity assessment with the composite index according to different treatment modalities in Behçet's syndrome: a multicentre study.

Mumcu G., Karacayli Ü., Yay M., Aksoy A., Taş M., Armağan B., et al.
Clinical and experimental rheumatology , sa.6, ss.98-104, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

104. Involvement of Iliofemoral and Axillary Arteries in PET-CT May Be Associated with Atherosclerotic Risk Factors in Takayasu's Arteritis

Kaymaz-Tahra S., ÖZGÜVEN S., Unal A. U., ALİBAZ ÖNER F., ÖNEŞ T., ERDİL T. Y., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded) identifier

105. Efficacy of TNF alpha Inhibitors for Refractory Vascular Behcet's Disease: A Multicenter Observational Study of 27 Patients

Aksoy A., YAZICI A., Omma A., ÇEFLE A., ÖNEN F., Tasdemir U., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded) identifier

106. Is the Risk of Tuberculosis Increased in Behcet's Disease Compared to Other Rheumatological Disorders After Anti-TNF-alpha Treatment?

Gazel U., Kocakaya D., Topcu I., Karatas H., KARABACAK M., Atagunduz P., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

107. Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018

Aydin S. Z., Robson J. C., Sreih A. G., Hill C., Alibaz-Oner F., Mackie S., et al.
JOURNAL OF RHEUMATOLOGY , cilt.46, sa.9, ss.1198-1201, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

108. Does illness perception associate with disease symptoms in Behçet's disease?

MUMCU G., YAĞAR F., Alibaz-Oner F., İNANÇ G. N., DİRESKENELİ R. H., ERGÜN T.
Internal and emergency medicine , cilt.14, sa.5, ss.691-697, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

109. Ocular findings and blood flow in patients with Takayasu arteritis: a cross-sectional study

ESEN F., ERGELEN R., Alibaz-Oner F., Celik G., Direskeneli H., Kazokoglu H.
BRITISH JOURNAL OF OPHTHALMOLOGY , cilt.103, sa.7, ss.928-932, 2019 (SCI-Expanded) identifier identifier identifier

110. Assessment of venous wall thickness with Doppler ultrasonography may be a diagnostic tool for Behcet's disease

Alibaz-Oner F., Direskeneli H.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.22, sa.5, ss.767-768, 2019 (SCI-Expanded) identifier identifier identifier

111. Venous vessel wall thickness in lower extremity is increased in male patients with Behcet's disease

Alibaz-Oner F., ERGELEN R., Mutis A., Erturk Z., Asadov R., MUMCU G., et al.
CLINICAL RHEUMATOLOGY , cilt.38, sa.5, ss.1447-1451, 2019 (SCI-Expanded) identifier identifier identifier

112. Oral health is a mediator for disease severity in patients with Behçet's disease: A multiple mediation analysis study.

Yay M., Celik Z., AKSOY A., Alibaz-Oner F., Inanc N., Ergun T., et al.
Journal of oral rehabilitation , cilt.46, sa.4, ss.349-354, 2019 (SCI-Expanded) identifier identifier identifier

113. Management of vascular Behçet's disease.

Alibaz-Oner F., Direskeneli H.
International journal of rheumatic diseases , cilt.22, ss.105-108, 2019 (SCI-Expanded) identifier identifier identifier

114. Fatigue in patients with Behcet's syndrome: relationship with quality of life, depression, anxiety, disability and disease activity

Ilhan B., Can M., Alibaz-Oner F., Yilmaz-Oner S., Polat-Korkmaz O., Ozen G., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.21, ss.2139-2145, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

115. Certolizumab pegol in the treatment of Takayasu arteritis

Novikov P. I., Smitienko I. O., Sokolova M. V., Alibaz-Oner F., Kaymaz-Tahra S., Direskeneli H., et al.
RHEUMATOLOGY , cilt.57, sa.12, ss.2101-2105, 2018 (SCI-Expanded) identifier identifier identifier

116. The assessment of contributing factors to oral ulcer presence in Behçet's disease: Dietary and non-dietary factors.

Iris M., Ozcikmak E., AKSOY A., Alibaz-Oner F., Inanc N., Ergun T., et al.
European journal of rheumatology , cilt.5, sa.4, ss.240-243, 2018 (Hakemli Dergi) identifier identifier

117. Clinical Features and Outcome of Patients with Polyarteritis Nodosa - a Global Collaborative Study

KARADAĞ Ö., Furuta S., Hocevar A., Gazel U., Gopaluni S., ARMAĞAN B., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded) identifier

118. Assessment of Severity and Risk Factors of Post-Thrombotic Syndrome in Vascular Behcet Disease: Muticentered Retrospective Study

AKSOY A., Colak S., Yagiz B., Coskun B. N., Omma A., Bolca N., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded) identifier

119. An Unmet Need for Oral Ulcer Activity in Patients with Behcet's Disease: A Multi-National Study

MUMCU G., Adesanya A., AKSOY A., Belem J. M. F. M., Cardin N. B., Alibaz-Oner F., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded) identifier

120. Long Term Follow-up Results of Takayasu Arteritis Cohort: A Tertiary-Single Center Study

Tahra S. K., Alibaz-Oner F., Direskeneli H.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded) identifier

121. Venous Vessel Wall Thickness in Lower Extremity Is Increased in Male Behcet's Disease Patients

Alibaz-Oner F., ERGELEN R., MÜTİŞ ALAN A., Erturk Z., Asadov R., Ergun T., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded) identifier

122. New Major Organ Involvement Is Lower in Young Male Behcet's Patients Compared to Retrospective Series: Five-Year Results of a Prospective Cohort

Alibaz-Oner F., ALDAĞ B., Karatay E., MUMCU G., Ergun T., Direskeneli H.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded) identifier

123. Assessment of Damage and Prognosis in Patients with Adult IgA Vasculitis: Retrospective Multicentered Cohort Study

Gazel U., Omma A., Sari A., Cansu D. U., YAZICI A., ÇEFLE A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded) identifier

124. Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients.

AKAR S., Cetin P., KALYONCU U., KARADAĞ Ö., Sari I., Cinar M., et al.
Arthritis care & research , cilt.70, sa.7, ss.1090-1094, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

125. Prevalence of inflammatory back pain and radiologic sacroiliitis is increased in patients with primary Sjögren's syndrome.

Eren R., Can M., Alibaz-Öner F., Yilmaz-Oner S., Yilmazer B., Cefle A., et al.
The Pan African medical journal , cilt.30, ss.98, 2018 (Scopus) identifier identifier identifier

126. Management of Behcet's disease

Alibaz-Oner F., Sawalha A. H., Direskeneli H.
CURRENT OPINION IN RHEUMATOLOGY , cilt.30, sa.3, ss.238-242, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

127. Impaired cardiac and vascular motion in patients with Takayasu's arteritis: A velocity vector imaging-based study

Yurdakul S., Alibaz-Oner F., Direskeneli H., Aytekin S.
EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.5, sa.1, ss.16-21, 2018 (ESCI) identifier identifier

128. The assessment of work productivity and activity impairment in patients with Behcet's disease: a multi-national study

MUMCU G., Celik Z., Adesanya A., Aksoy A., Belem J. M. F. M., Cardin N., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded) identifier

129. Venous vessel wall thickness in lower extremity is increased in male Behcet's disease patients

Alibaz-Oner F., ERGELEN R., Mutis A., Erturk Z., Asadov R., Ergun T., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded) identifier

130. An unmet need for oral ulcer activity in patients with Behcet's disease: a multi-national study

MUMCU G., Adesenya A., Aksoy A., Belem J. M. F. M., Cardin N., Alibaz-Oner F., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded) identifier

131. Oral health is a mediator for disease severity in patients with Behcet's disease: a Multiple mediation analysis study

MUMCU G., Yay M., Celik Z., Aksoy A., Alibaz-Oner F., Inanc N., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded) identifier

132. Fatigue in systemic lupus erythematosus Association with disease activity, quality of life and psychosocial factors

Yilmaz-Oner S., Ilhan B., Can M., Alibaz-Oner F., Polat-Korkmaz O., Ozen G., et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE , cilt.76, sa.10, ss.913-919, 2017 (SCI-Expanded) identifier identifier identifier

133. Limited reliability of radiographic assessment of spinal progression in ankylosing spondylitis

Aydin S. Z., Gunal E. K., Kurum E., AKAR S., Mungan H. E., Alibaz-Oner F., et al.
RHEUMATOLOGY , cilt.56, sa.12, ss.2162-2169, 2017 (SCI-Expanded) identifier identifier identifier

134. Development of a core set of outcome measures for large-vessel vasculitis: Report from OMERACT 2016

Sreih A. G., Alibaz-Oner F., Kermani T. A., Aydin S. Z., Cronholm P. F., Davis T., et al.
Journal of Rheumatology , cilt.44, sa.12, ss.1933-1937, 2017 (SCI-Expanded) identifier identifier identifier

135. Assessment of Damage and Prognosis in Patients with Adult IgA Vasculitis: Retrospective Multicentered Cohort Study

Alibaz-Oner F., Omma A., Sari A., KARADAĞ Ö., Cansu D. U., Bes C., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded) identifier

136. Patient-reported outcomes in Takayasu's arteritis

Alibaz-Oner F., Sreih A. G., Merkel P. A., Direskeneli H.
PRESSE MEDICALE , cilt.46, 2017 (SCI-Expanded) identifier identifier

137. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.

Deniz R., Tulunay-Virlan A., Ozdemir F. T., Unal A. U., Ozen G., Alibaz-Oner F., et al.
Immunological investigations , cilt.46, sa.5, ss.518-525, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

138. Clinical Spectrum of Medium-Sized Vessel Vasculitis

Alibaz-Oner F., Koster M. J., Crowson C. S., Makol A., Ytterberg S. R., Salvarani C., et al.
ARTHRITIS CARE & RESEARCH , cilt.69, sa.6, ss.884-891, 2017 (SCI-Expanded) identifier identifier identifier

139. Oral ulcer activity in Behcet's disease: Poor medication adherence is an underestimated risk factor.

MUMCU G., Alibaz-Oner F., Oner S. Y., Ozen G., Atagunduz P., Inanc N., et al.
European journal of rheumatology , cilt.4, sa.2, ss.109-112, 2017 (TRDizin) identifier identifier

140. Criteria sets for primary Sjogren's syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features

KABASAKAL Y., KİTAPÇIOĞLU G., KARABULUT G., Tezcan M., Balkarli A., Aksoy A., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.37, sa.5, ss.675-684, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

141. Reply to: Assessing the role of pentraxin-3 in Takayasu's arteritis. De Luca G. et al.

Alibaz-Oner F., Direskeneli H.
Clinical and experimental rheumatology , ss.222, 2017 (SCI-Expanded) identifier identifier

142. Reply to: Assessing the role of pentraxin-3 in Takayasu's arteritis

Alibaz-Oner F., Direskeneli H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.35, sa.1, 2017 (SCI-Expanded) identifier

143. Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort

Omma A., Erer B., Karadag O., Yilmaz N., Alibaz-Oner F., Yildiz F., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.35, sa.1, 2017 (SCI-Expanded) identifier identifier identifier

144. Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis

Alibaz-Oner F., Koster M. J., Unal A. U., Yildirim H. G., ÇIKIKÇI C., Schmidt J., et al.
Rheumatology (United Kingdom) , cilt.56, sa.11, ss.1939-1944, 2017 (SCI-Expanded) identifier identifier identifier

145. The assessment of work productivity and activity impairment in Behcet's disease

MUMCU G., Lehimci F., Fidan O., Guk H., Alpar U., Unal A. U., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.47, sa.2, ss.535-541, 2017 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

146. HEALTH RELATED OUTCOMES OF IMPORTANCE TO PATIENTS WITH TAKAYASU’xxS ARTERITIS

Sreih A. G., Alibaz-Oner F., Easley E., Davis T., MUMCU G., Milman N., et al.
CLINICAL EXPERIMENTAL RHEUMATOLOGY , cilt.36, ss.51-57, 2017 (SCI-Expanded) identifier identifier

147. Vitamin D Levels in Takayasu's Arteritis and a Review of the Literature on Vasculitides

Alibaz-Oner F., Asmaz-Haliloglu O., Gogas-Yavuz D., Can M., HAKLAR G., Direskeneli H.
JOURNAL OF CLINICAL LABORATORY ANALYSIS , cilt.30, sa.5, ss.529-533, 2016 (SCI-Expanded) identifier identifier identifier

148. Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular Behçet's disease.

Alibaz-Oner F., ALDAĞ B., Aldag M., Unal A. U., MÜTİŞ ALAN A., TOPTAŞ T., et al.
Journal of vascular surgery. Venous and lymphatic disorders , cilt.4, sa.3, ss.301-6, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

149. Assessment of the New 2012 EULAR/ACR Clinical Classification Criteria for Polymyalgia Rheumatica: A Prospective Multicenter Study

Ozen G., Inanc N., Unal A. U., Bas S., Kimyon G., Kisacik B., et al.
JOURNAL OF RHEUMATOLOGY , cilt.43, sa.5, ss.893-900, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

150. Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort

KALYONCU U., Solmaz D., Emmungil H., YAZICI A., KAŞİFOĞLU T., Kimyon G., et al.
Journal of Autoimmunity , cilt.69, ss.59-63, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

151. The IL-33 gene is related to increased susceptibility to systemic sclerosis

KOCA S. S., Pehlivan Y., KARA M., Alibaz-Oner F., ÖZTUZCU S., Yilmaz N., et al.
Rheumatology International , cilt.36, sa.4, ss.579-584, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

152. A relationship between spinal new bone formation in ankylosing spondylitis and the sonographically determined Achilles tendon enthesophytes

Aydin S. Z., Can M., Alibaz-Oner F., KESER G., Kurum E., İNAL V., et al.
Rheumatology International , cilt.36, sa.3, ss.397-404, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

153. Investigation of the association between Rho/Rho-kinase gene polymorphisms and systemic sclerosis

Pehlivan Y., Yolbas S., ÇETİN G. Y., Alibaz-Oner F., Cagatay Y., Yilmaz N., et al.
Rheumatology International , cilt.36, sa.3, ss.421-427, 2016 (SCI-Expanded) identifier identifier identifier

154. Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up

Alibaz-Oner F., Aksu K., Yentur S. P., Keser G., Saruhan-Direskeneli G., Direskeneli H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.3, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

155. Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12

Aydin S. Z., Direskeneli H., Sreih A., Alibaz-Oner F., Gul A., Kamali S., et al.
JOURNAL OF RHEUMATOLOGY , cilt.42, sa.12, ss.2465-2469, 2015 (SCI-Expanded) identifier identifier identifier

156. Association of TRPM Channel Gene Polymorphisms with Systemic Sclerosis.

Oztuzcu S., Onat A., Pehlivan Y., Alibaz-Oner F., Donmez S., Cetin G., et al.
In vivo (Athens, Greece) , cilt.29, ss.763-70, 2015 (SCI-Expanded) identifier identifier identifier

157. Association of TRPM channel gene polymorphisms with systemic sclerosis

ÖZTUZCU S., Onat A. M., Pehlivan Y., Alibaz-Oner F., Donmez S., ÇETİN G. Y., et al.
In Vivo , cilt.29, sa.6, ss.763-770, 2015 (SCI-Expanded) identifier identifier identifier

158. Update on Takayasu's arteritis

Alibaz-Oner F., Direskeneli H.
PRESSE MEDICALE , cilt.44, sa.6, 2015 (SCI-Expanded) identifier identifier

159. Serum cytokine profiles in Takayasu's arteritis: search for biomarkers

Alibaz-Oner F., Yentur S. P., Saruhan-Direskeneli G., Direskeneli H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.2, 2015 (SCI-Expanded) identifier identifier identifier

160. Activation of the JAK/STAT pathway in Behcet's disease

Tulunay A., Dozmorov M. G., Ture-Ozdemir F., Yilmaz V., Eksioglu-Demiralp E., Alibaz-Oner F., et al.
GENES AND IMMUNITY , cilt.16, sa.2, ss.170-175, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

161. Patients with Takayasu's arteritis having persistent acute-phase response usually have an increased major vessel uptake by 18F-FDG-PET/CT

Alibaz-Oner F., DEDE F., ÖNEŞ T., TUROĞLU H. T., Direskeneli H.
MODERN RHEUMATOLOGY , cilt.25, sa.5, ss.752-755, 2015 (SCI-Expanded) identifier identifier identifier

162. Identification of susceptibility loci in IL6, RPS9/LILRB3, and an intergenic locus on chromosome 21q22 in takayasu arteritis in a genome-wide association study

Renauer P. A., Saruhan-Direskeneli G., Coit P., Adler A., AKSU K., KESER G., et al.
Arthritis and Rheumatology , cilt.67, sa.5, ss.1361-1368, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

163. Behçet disease with vascular involvement: Effects of different therapeutic regimens on the incidence of new relapses

Alibaz-Oner F., Karadeniz A., YILMAZ S., Balkarli A., Kimyon G., YAZICI A., et al.
Medicine (United States) , cilt.94, sa.6, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

164. Assessment of patients with Takayasu arteritis in routine practice with Indian Takayasu clinical activity score

Alibaz-Oner F., Aydin S. Z., Akar S., AKSU K., Kamali S., Yucel E., et al.
Journal of Rheumatology , cilt.42, sa.8, ss.1443-1447, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

165. Familial Mediterranean fever gene (MEFV) mutations and disease severity in systemic lupus erythematosus (SLE): implications for the role of the E148Q MEFV allele in inflammation

Deniz R., Ozen G., Yilmaz-Oner S., Alibaz-Oner F., Erzik C., Aydin S. Z., et al.
Lupus , cilt.24, sa.7, ss.705-711, 2015 (SCI-Expanded) identifier identifier identifier

166. Unmet need in Behcet's disease: most patients in routine follow-up continue to have oral ulcers.

Alibaz-Oner F., MUMCU G., Kubilay Z., Ozen G., Celik G., Karadeniz A., et al.
Clinical rheumatology , cilt.33, sa.12, ss.1773-6, 2014 (SCI-Expanded) identifier identifier identifier

167. Diagnostic dilemma of paraneoplastic arthritis: Case series

Kisacik B., Onat A. M., KAŞİFOĞLU T., Pehlivan Y., Pamuk O. N., Dalkilic E., et al.
International Journal of Rheumatic Diseases , cilt.17, sa.6, ss.640-645, 2014 (SCI-Expanded) identifier identifier identifier

168. Epigenome-Wide Scan Identifies a Treatment-Responsive Pattern of Altered DNA Methylation Among Cytoskeletal Remodeling Genes in Monocytes and CD4+T Cells From Patients With Behcet's Disease

Hughes T., Ture-Ozdemir F., Alibaz-Oner F., Coit P., Direskeneli H., Sawalha A. H.
ARTHRITIS & RHEUMATOLOGY , cilt.66, sa.6, ss.1648-1658, 2014 (SCI-Expanded) identifier identifier identifier

169. Impaired endothelial function in patients with Takayasu's arteritis

Alibaz-Oner F., Yurdakul S., Aytekin S., Direskeneli H.
Acta Cardiologica , cilt.69, sa.1, ss.45-49, 2014 (SCI-Expanded) identifier identifier identifier

170. Evaluation of asymptomatic venous disease by venous Doppler ultrasonography in patients with Behcet's disease without overt thrombosis.

Alibaz-Oner F., Karatay E., Akpinar I. N., Ergun T., Direskeneli H.
Clinical rheumatology , cilt.33, sa.2, ss.277-80, 2014 (SCI-Expanded) identifier identifier identifier

171. Clinically silent Crohn's disease in a patient with Takayasu's Arteritis unresponsive to conventional therapies

Yilmaz N., Can M., Alibaz-Oner F., Direskeneli H.
Rheumatology International , cilt.33, sa.12, ss.3091-3093, 2013 (SCI-Expanded) identifier identifier identifier

172. TIR-domain-containing adaptor protein gene TIRAP S180L polymorphism is not increased in behçet's disease patients in two ethnic cohorts

Turunc G., Coskun D., Alibaz-Oner F., Coit P., Duzgun N., ALPSOY E., et al.
Clinical and Experimental Rheumatology , cilt.31, 2013 (SCI-Expanded) identifier identifier identifier

173. Impaired quality of life, disability and mental health in Takayasu's arteritis.

Yilmaz N., Can M., Oner F., Kalfa M., Emmungil H., KARADAĞ Ö., et al.
Rheumatology (Oxford, England) , cilt.52, sa.10, ss.1898-904, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

174. Identification of multiple genetic susceptibility loci in Takayasu arteritis

Saruhan-Direskeneli G., Hughes T., AKSU K., KESER G., Coit P., Aydin S. Z., et al.
American Journal of Human Genetics , cilt.93, sa.2, ss.298-305, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

175. PATIENTS WITH TAKAYASU'S ARTERITIS HAVING PERSISTENT ACUTE PHASE RESPONSE USUALLY HAVE AN INCREASED MAJOR VESSEL UPTAKE BY 18F-FDG-PET/CT

Alibaz-Oner F., DEDE F., ÖNEŞ T., TUROĞLU H. T., Direskeneli H.
ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.494, 2013 (SCI-Expanded) identifier

176. TIR-domain-containing adaptor protein gene TIRAP S180L polymorphism is not increased in Behçet's disease patients in two ethnic cohorts.

Turunc G., Coskun D., Alibaz-Oner F., Coit P., Duzgun N., Alpsoy E., et al.
Clinical and experimental rheumatology , cilt.31, sa.3 Suppl 77, ss.54-6, 2013 (SCI-Expanded) identifier identifier identifier

177. Advances in the diagnosis, assessment and outcome of Takayasu's arteritis

Alibaz-Oner F., Aydin S. Z., Direskeneli H.
CLINICAL RHEUMATOLOGY , cilt.32, sa.5, ss.541-546, 2013 (SCI-Expanded) identifier identifier identifier

178. Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience

Can M., Alibaz-Oner F., Yilmaz-Oner S., Atagunduz P., Inanc N., Direskeneli H.
CLINICAL RHEUMATOLOGY , cilt.32, sa.1, ss.87-90, 2013 (SCI-Expanded) identifier identifier identifier

179. Impact of levosimendan on Right ventricular functions by using novel tissue Doppler derived indices in patients with ischaemic left ventricular failure

Alibaz-Oner F., Gurbuz O. Z., Oner E., Yurdakul S., Erguney M.
Kardiologia Polska , cilt.71, sa.10, ss.1036-1041, 2013 (SCI-Expanded) identifier identifier identifier

180. Presence of Fibromyalgia in Patients with Takayasu's Arteritis

Alibaz-Oner F., Can M., Ilhan B., Polat O., MUMCU G., Direskeneli H.
INTERNAL MEDICINE , cilt.52, sa.24, ss.2739-2742, 2013 (SCI-Expanded) identifier identifier identifier

181. A case of Takayasu's arteritis associated with familial Mediterranean fever

Alibaz-Oner F., Yilmaz N., Can M., Direskeneli H.
Clinical and Experimental Rheumatology , cilt.30, sa.SUPPL.72, 2012 (SCI-Expanded) identifier identifier identifier

182. The Results of Streptokinase Therapy in Acute Pulmonary Embolism with Intermediate and High Risk

GÜRBÜZ Ö. Z., ALİBAZ ÖNER F., AKYAY A. İ., COŞKUN Y., ERGÜNEY M.
TURKISH THORACIC JOURNAL , cilt.13, sa.4, ss.6-10, 2012 (Hakemli Dergi)

183. Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinical hypothyroidism

Cebeci E., Alibaz-Oner F. A., Usta M., Yurdakul S., Erguney M.
Journal of Investigative Medicine , cilt.60, sa.1, ss.23-28, 2012 (SCI-Expanded) identifier identifier identifier

184. Evaluation of the effect of L-thyroxin therapy on endothelial functions in patients with subclinical hypothyroidism

Oner F., Yurdakul S., Oner E., Uzum A. K., Erguney M.
ENDOCRINE , cilt.40, sa.2, ss.280-284, 2011 (SCI-Expanded) identifier identifier identifier

185. Vascular endothelial function assessed by a noninvasive ultrasound method and serum asymmetric dimethylarginine concentrations in mild-to-moderate plaque-type psoriatic patients.

Usta M., Yurdakul S., Aral H., Turan E., Oner E., Inal B. B., et al.
Clinical biochemistry , cilt.44, sa.13, ss.1080-1084, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

186. Evaluation of the eff ect of l-thyroxin therapy on cardiac functions by using novel tissue Doppler-derived indices in patients with subclinical hypothyroidism

Alibaz Oner F., Yurdakul S., Oner E., Kubat Uzum A., Erguney M.
Acta Cardiologica , cilt.66, sa.1, ss.47-55, 2011 (SCI-Expanded) identifier identifier identifier

187. Evaluation of ventricular functions using tissue Doppler echocardiography in patients with subclinical hypothyroidism.

Oner F., Yurdakul S., Oner E., Arslantaş M., Usta M., Ergüney M.
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , cilt.39, ss.129-36, 2011 (SCI-Expanded) identifier identifier

188. The Effect of Glysemic Control on Myocardial Performance Index in Patients with Type 2 Diabetes Mellitus

ALİBAZ ÖNER F., GÜRCAN Z., UZUNHASAN I., ERGÜNEY M.
ERCIYES MEDICAL JOURNAL , cilt.33, ss.183-188, 2011 (ESCI) Sürdürülebilir Kalkınma

189. Girişimsel tedavi olanağı olmayan merkezimizde miyokard infarktüslü hastaların 2 yıllık mortalite oranları

ALİBAZ ÖNER F., ERGÜNEY M., ARSLANTAŞ M. K.
MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL , cilt.44, ss.72-75, 2010 (Hakemli Dergi)

190. BOZULMUŞ AÇLIK GLUKOZU OLAN AKUT KORONER SENDROMLU HASTALARDA HASTANE İÇİ MORTALİTE

UÇUCU M., ALİBAZ ÖNER F., YURDAKUL S., ERGUNEY M.
Marmara Medical Journal , cilt.23, sa.2, ss.257-262, 2010 (Scopus)

191. Intoxication of diltiazem Diltiazem intoksikasyonu

Alibaz-Öner F., Gürcan Z., Yurdakul S., Ergüney M.
Goztepe Tip Dergisi , cilt.23, sa.1, ss.28-29, 2008 (Scopus) identifier

192. Relation of complement activation and peak CK-MB level at ST elevation myocardial infarction ST yükselmeli miyokard infarktüsünde zirve CK-MB düzeyi ile kompleman aktivasyonunun ilişkisi

Alibaz Öner F., Gedik H., Ünalan N., Pişkinpaşa M. E., Ergüney M.
Goztepe Tip Dergisi , cilt.22, sa.1, ss.18-19, 2007 (Scopus) identifier

193. Anemia and heart failure Anemi ve kalp yetersizliǧi

Taşkiran H., Alibaz Öner F., Pişkinpaşa M. E., Ergüney M.
Goztepe Tip Dergisi , cilt.21, sa.3, ss.138-141, 2006 (Scopus) identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 32

1. MAIT cells are decreased in the peripheral blood of Behçet's disease patients

TAZEGÜL G., ALİBAZ ÖNER F., TERZİOĞLU M. E., DİRESKENELİ R. H., YAZISIZ V.
23rd European Congress of Internal Medicine, FLORANSA, İtalya, 5 - 08 Mart 2025, (Özet Bildiri)

2. Behçet hastalığında MAİT hücrelerinin rolü var mıdır?

TAZEGÜL G., ALİBAZ ÖNER F., TERZİOĞLU M. E., DİRESKENELİ R. H., YAZISIZ V.
24. Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Ekim 2024, (Özet Bildiri)

3. Patients with Oral Ulcers Display High Levels of Salivary Acidic Glycoproteins in Behçet’s Syndrome

ÇEVİK ARAS H., POLAT AKMANSOY B., SARI F. B., AKMANSOY Ş. C., TATLI İ., ALİBAZ ÖNER F., et al.
The Joint Meeting of The European Association of Oral Medicine Region V, İstanbul, Türkiye, 25 Ekim 2024, ss.40, (Özet Bildiri)

4. Identifying Low Disease Activity and Its Related Factors in Behçet's Syndrome through K-Means Cluster Analysis and Correspondence Analysis

POLAT AKMANSOY B., AKSOY B., ÇANDERELİ Z. Ö., SACOOR S., GOKANİ B., ALİBAZ ÖNER F., et al.
The Joint Meeting of The European Association of Oral Medicine Region V, İstanbul, Türkiye, 25 - 27 Ekim 2024, (Özet Bildiri)

5. C-reaktif protein/albümin oranı anti-nötrofil sitoplazmik antikor ilişkili vaskülitte hastalık aktivitesi ile ilişkilidir

BARUTÇU ATAŞ D., Kumru Şahin G., ŞENGÜL Ş., KAYA B., PAYDAŞ S., ALİBAZ ÖNER F., et al.
Uluslararası Katılımlı 10. Güncel Böbrek Hastalıkları Hipertansiyon ve Transplantasyon Kongresi, Sapanca/Adapazarı, Türkiye, 15 - 19 Eylül 2021, ss.61, (Özet Bildiri)

6. MO174FIBROSCAN DETECTION OF FATTY LIVER AND LIVER FIBROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS

Yetginoğlu Ö., BARUTÇU ATAŞ D., VELİOĞLU A., ARIKAN İ. H., YILMAZ Y., ALİBAZ ÖNER F., et al.
58th ERA-EDTA congress fully virtual June 5-8 2021, Almanya, 5 - 08 Haziran 2021, cilt.36, ss.172, (Özet Bildiri)

7. ISOLATED PULMONARY VASCULITIS DIAGNOSED HISTOPATHOLOGICALLY AFTER PULMONARY ENDARTERECTOMY: A CASE SERIES

Gazel U., KOCAKAYA D., Salcinkaya Y., Inanc N., YILDIZELİ B., Alibaz-Oner F., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri) identifier

8. IS THE RISK OF TUBERCULOSIS INCREASED IN BEHCET'S DISEASE COMPARED TO OTHER RHEUMATOLOGICAL DISORDERS AFTER ANTI-TNF-A TREATMENT?

Gazel U., KOCAKAYA D., Topcu I., Karatas H., Karabacak M., ATAGÜNDÜZ M. P., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, ss.102, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

9. Vitamin d level is decreased in patients with takayasu s arteritis but is unassociated with the presence of fibromyalgia

ALİBAZ ÖNER F., ASMAZ HALİLOGLU Ö., YAVUZ D., CAN M., DİRESKENELİ R. H.
Annual European Congress of Rheumatology EULAR, 2013, 12 - 15 Haziran 2013, cilt.72, ss.925, (Özet Bildiri)

10. Impaired endothelial function in patients with takayasu s arteritis

ALİBAZ ÖNER F., YURDAKUL S., AYTEKİN S., DİRESKENELİ R. H.
Annual European Congress of Rheumatology EULAR, 2013, 12 - 15 Haziran 2013, cilt.72, ss.494

11. Assessment of patients with takayasu s arteritis in a routine clinical follow up with indian takayasu clinical activity score itas2010

ALİBAZ ÖNER F., DİRESKENELİ R. H.
Annual European Congress of Rheumatology EULAR, 2013, 12 - 15 Haziran 2013, cilt.72, ss.494

12. Evaluation of asymptomatic venous disease by venous doppler ultrasonography in patients with behcet s disease without overt thrombosis

ALİBAZ ÖNER F., KARATAY E., AKPINAR İ. N., ERGUN S. A. T., DİRESKENELİ R. H.
Annual European Congress of Rheumatology EULAR, 2013, 12 - 15 Haziran 2013, cilt.72, ss.494

13. Unmet need in behcet s disease most patients are not in complete remission in the long term follow up

ALİBAZ ÖNER F., MUMCU G., KUBILAY Z., ÖZEN G., ÇELİK G., KARADENİZ A., et al.
Annual European Congress of Rheumatology EULAR, 2013, 12 - 15 Haziran 2013, cilt.72, ss.495

14. Takayasu arteritli hastalarda D vitamini seviyesidüsüktür

ALİBAZ ÖNER F., ASMAZ HALİLOGLU Ö., YAVUZ D., CAN M., DİRESKENELİ R. H.
13.Ulusal Romatoloji Kongresi, Türkiye, 13 - 17 Ekim 2012, cilt.4, ss.132

15. Takayasu arteritinde artmis fibromyalji sikligive yorgunluk gözlenmedi

ALİBAZ ÖNER F., CAN M., İLHAN B., POLAT Ö., DİRESKENELİ R. H.
13.Ulusal Romatoloji Kongresi, Türkiye, 13 - 17 Ekim 2012, cilt.4, ss.76

16. Behçet hastaligi tedavisinde ne kadar basariliyizUzun dönem izlemde çogu hasta aktif seyrediyor

ALİBAZ ÖNER F., MUMCU G., ÖZEN G., KUBILAY Z., CAN M., YIILMAZ ÖNER S., et al.
13.Ulusal Romatoloji Kongresi, Türkiye, 13 - 17 Ekim 2012, cilt.4, ss.158

17. Erken artritli hastalarda 2010 ACR EULAR romatoidartrit siniflandirma kriterlerinin tani ve prognozdakidegeri

ALİBAZ ÖNER F., ATAGÜNDÜZ M. P., DİRESKENELİ R. H., İNANÇ G. N.
13.Ulusal Romatoloji Kongresi, Türkiye, 13 - 17 Ekim 2012, cilt.4, ss.73

18. Behçet hastaliginda fibromiyalji hastalik aktivitesi vemental durum ile iliskilidir

CAN M., ALİBAZ ÖNER F., ÖNER S., İLHAN B., POLAT Ö., İNANÇ G. N., et al.
13.Ulusal Romatoloji Kongresi, Türkiye, 13 - 17 Ekim 2012, cilt.4, ss.160

19. Primer Sjögren sendromunda inflamatuar bel a r s ve aksiyel spondiloartropati s kl

EREN R., CAN M., ALİBAZ ÖNER F., YILMAZ ONER S., AKPINAR İ. N., YILMAZER B., et al.
13.Ulusal Romatoloji Kongresi, Türkiye, 13 - 17 Ekim 2012, cilt.4, ss.60-61

20. Romatoid artritli hastalarda artmis yorgunluk hemhastalik aktivitesi ve fonksiyonel kayip hem de mentaldurum ile iliskilidir

İLHAN B., CAN M., ALİBAZ ÖNER F., ÖNER S., İNANÇ G. N., DİRESKENELİ R. H.
13.Ulusal Romatoloji Kongresi, Türkiye, 13 - 17 Ekim 2012, cilt.4, ss.125-126

21. Takayasu arteritli hastalarda uyku kalitesinindegerlendirilmesi

ALİBAZ ÖNER F., POLAT Ö., DİRESKENELİ R. H.
13.Ulusal Romatoloji Kongresi, Türkiye, 13 - 17 Ekim 2012, cilt.4, ss.132-133

22. Behçet hastalarInda yorgunluk artmis veyasam kalitesi düsmüstür

İLHAN B., CAN M., ALİBAZ ÖNER F., ÖNER S., İNANÇ G. N., ERGUN S. A. T., et al.
13.Ulusal Romatoloji Kongresi, Türkiye, 13 Ekim 2012, cilt.4, ss.157

23. Eriskin Still hastaligi Türkiye verileri Erken dönemsonuçlar

KALYONCU U., SOLMAZ D., EMMUNGIL H., YAZICI A., KAŞİFOĞLU T., KİMYON G., et al.
13.Ulusal Romatoloji Kongresi, Türkiye, 13 - 17 Ekim 2012, cilt.4, ss.64-65

24. Takayasu arteritinde hasar unsurlari ve hasarin yasamkalitesi ile iliskisi Çok merkezli çalismanin sonuçlari

OMMA A., ERER S. B., KARADAĞ Ö., YILMAZ N., ALİBAZ ÖNER F., YILDIZ F., et al.
13.Ulusal Romatoloji Kongresi, Türkiye, 13 - 17 Ekim 2012, cilt.4, ss.53-54

25. Fibromyalgia in behÇet s disease is associated with disease activity

CAN M., ALİBAZ ÖNER F., ÖNER S., ERGUN S. A. T., MUMCU G., DİRESKENELİ R. H.
Annual European Congress of Rheumatology EULAR, 2012, 6 - 09 Haziran 2012, cilt.71, ss.700, (Özet Bildiri)

26. Quality of life and fatigue in patients with behcet s disease

CAN M., ALİBAZ ÖNER F., İLHAN B., ÖNER S., İNANÇ G. N., ERGUN S. A. T., et al.
Annual European Congress of Rheumatology EULAR, 2012, 6 - 09 Haziran 2012, cilt.71, ss.682

27. Accelerated infusion rates of RITUXIMAB is well tolerated and safe in rheumatology practice A single center experience

CAN M., ALİBAZ ÖNER F., ÖNER S., ATAGÜNDÜZ M. P., İNANÇ G. N., DİRESKENELİ R. H.
Annual European Congress of Rheumatology EULAR, 2012, 6 - 09 Haziran 2012, cilt.71, ss.670, (Özet Bildiri)

28. Presence of fibromyalgia and fatigue is not increased in patients with takayasu s arteritis

ALİBAZ ÖNER F., CAN M., DİRESKENELİ R. H.
Annual European Congress of Rheumatology EULAR, 2012, 6 - 09 Haziran 2012, cilt.71, ss.390 identifier

29. Impairment in aortic elastic properties and mechanics of carotid artery system in patients with takayasu s arteritis

ALİBAZ ÖNER F., YURDAKUL S., TAYYARECİ Y., DİRESKENELİ R. H., AYTEKİN S.
Annual European Congress of Rheumatology EULAR, 2012, 6 - 09 Haziran 2012, cilt.71, ss.607 identifier

30. Takayasu Arteriti Olan Hastalarda Endotel Fonksiyonlarının ve Karotis İntima Media Kalınlığının Değerlendirilmesi

YURDAKUL S., ALİBAZ ÖNER F., TAYYARECİ Y., DİRESKENELİ R. H., AYTEKİN S.
12.Ulusal Romatoloji Kongresi, Türkiye, 16 - 20 Ekim 2011, cilt.3, ss.126

31. Hızlı Rituximab Infuzyon Deneyimi Güvenilirlik ve Tolerans sorunu yaşanmamaktadır

CAN M., ALİBAZ ÖNER F., ÖNER S., ATAGÜNDÜZ M. P., İNANÇ G. N., DİRESKENELİ R. H.
12.Ulusal Romatoloji Kongresi, Türkiye, 16 - 20 Ekim 2011, cilt.3, ss.89

32. Takayasu Arteritinde Büyük Arterlerde Elastikiyet Kaybı Sertlikte Artış ve Mekanik Özelliklerde Bozulma Gözlenmektedir

YURDAKUL S., ALİBAZ ÖNER F., TAYYARECİ Y., DİRESKENELİ R. H., AYTEKİN S.
12.Ulusal Romatoloji Kongresi, Türkiye, 16 - 20 Ekim 2011, cilt.3, ss.126-127
Kitaplar 5

1. Prognosis and Disease Activity

Alibaz Öner F., Direskeneli R. H.
Large and Medium Size Vessel and Single Organ Vasculitis, Carlo Salvarani,Luigi Boiardi,Francesco Muratore, Editör, Springer, London/Berlin , Zürich, ss.119-130, 2021

2. Treatment

Alibaz Öner F.
Large and Medium Size Vessel and Single Organ Vasculitis, Carlo Salvarani,Luigi Boiardi,Francesco Muratore., Editör, Springer, London/Berlin , Zürich, ss.131-143, 2021

3. İmaging

Alibaz Öner F., Direskeneli R. H.
Large and Medium Size Vessel and Single Organ Vasculitis, Carlo Salvarani,Luigi Boiardi,Francesco Muratore, Editör, Springer, London/Berlin , Zürich, ss.105-117, 2021

4. Clinical Manifestations, Differential Diagnosis, and Laboratory Markers

Alibaz Öner F., Direskeneli R. H.
Large and Medium Size Vessel and Single Organ Vasculitis, Carlo Salvarani,Luigi Boiardi,Francesco Muratore, Editör, Springer, London/Berlin , Zürich, ss.35-45, 2021

5. Behçet's Disease: Clinical Features

ALİBAZ ÖNER F., DİRESKENELİ R. H.
Neuro-Behçet’s Disease, Erdem Tüzün, Murat Kürtüncü, Editör, Springer, ss.55-62, 2021
Metrikler

Yayın

276

Yayın (WoS)

215

Yayın (Scopus)

185

Atıf (WoS)

1661

H-İndeks (WoS)

10

Atıf (Scopus)

2881

H-İndeks (Scopus)

30

Atıf (Scholar)

4393

H-İndeks (Scholar)

38

Atıf (TrDizin)

2

H-İndeks (TrDizin)

1

Atıf (Sobiad)

33

H-İndeks (Sobiad)

3

Atıf (Diğer Toplam)

2

Proje

1

Tez Danışmanlığı

5

Açık Erişim

19
BM Sürdürülebilir Kalkınma Amaçları